Controlling shape morphing and cell release in engineered living materials

Engineered living materials (ELMs) derive functionality from both a polymer matrix and the behavior of living cells within the material. The long-term goal of this work is to enable a system of ELM-based medical devices with both mechanical and bioactive functionality. Here, we fabricate multifunctional, stimuli-responsive ELMs comprised of acrylic hydrogel matrix and Escherichia coli. These ELMs undergo controlled changes in form and have a controlled release of bacteria from the composite. We hypothesize that the mechanical forces associated with cell proliferation within a covalently-crosslinked, non-degradable hydrogel are responsible for both phenomena. At constant cell loading, increased hydrogel elastic modulus significantly reduces both cell delivery and volume change associated with cell proliferation. ELMs that change volume over 100 % also result in ~106 colony forming units/mL in the growth medium over 2 h after 1 day of growth. At constant monomer feed ratios, increased cell loading leads to significantly increased cell delivery. Finally, these prokaryotic ELMs were investigated for their potential to deliver a probiotic that can reduce the proliferation of a uropathogen in vitro. Controlling the long-term delivery of bacteria could potentially be used in biomedical applications to modulate microbial communities within the human body.

Preparation and shape change of silver nanoparticles (AgNPs) loaded on the dialdehyde cellulose by in-situ synthesis method

With the improvement of medical and health care level in our society, the demand for antibacterial materials is increasing. In this work, we prepared the antibacterial materials by loading silver nanoparticles (AgNPs) on the dialdehyde cellulose (DAC) with in-situ synthesis method. DAC was prepared by pretreating cellulose fiber with sodium metaperiodate (NaIO₄) to convert the hydroxyl group into aldehyde group, and then reacted with silver nitrate (AgNO₃) to obtain AgNPs loaded on DAC. UV-Vis results show that the characteristic absorption peak of AgNPs at 428 nm appeared in the AgNPs-loaded-DAC. It was observed by SEM that the spherical AgNPs were distributed uniformly on the DAC surface without obvious flocculation. The color of DAC was not changed significantly, indicating that a small amount of AgNPs was loaded. In addition, sodium citrate (Na₃C₆H₅O₇) was added in the reaction of DAC and AgNO₃ and its effect on the formation of AgNPs was studied. The results demonstrated that the color of DAC turned deeper and finally dark yellow with reaction time extended. When the reaction time was 60 h, the spherical AgNPs were gradually grown and transformed into triangular prism on the DAC surface. The antibacterial properties of AgNPs showed inhibition zones of 4.90 mm and 7.35 mm (60 h) against Gram-negative (E. coli) and Gram-positive (S. aureus), respectively, which increased by 40.00% and 14.85% compared with spherical AgNPs (2.5 h) obtained without Na₃C₆H₅O₇. The research of AgNPs-loaded cellulose-based materials promotes the development prospect of new nano-antibacterial materials.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s10570-022-04692-6.

Significant advancements of 4D printing in the field of orthopaedics

Researchers, engineers and doctors are continuously focusing on the development of orthopaedics parts characterised by the required responses. So, advanced manufacturing technologies are introduced to fulfil various previously faced challenges. 4D printing provides rapid development with its capability of customization of smart orthopaedics implants and appropriate surgical procedure. This technology opens up the making of innovative, adaptable internal splints, stents, replacement of tissues and organs. Thus, to write this review based article, relevant papers on 4D printing in medical/orthopaedics and smart materials are identified and studied. 4D printed parts show the capability of shape-changing and self-assembly to perform the required functions, which otherwise manufactured parts are not providing. Smart orthopaedics implants are used for spinal deformities, fracture fixation, joint, knee replacement and other related orthopaedics applications. This paper briefs about the 4D printing technology with its major benefits for orthopaedics applications. Today various smart materials are available, which could be used as raw material in 4D printing, and we have discussed capabilities of some of them. Due to the ability of shape-changing, smart implants can change their shape after being implanted in the patient body. Finally, twelve significant advancements of 4D printing in the field of orthopaedics are identified and briefly provided. Thus, 4D printing help to provide a significant effect on personalised treatments.

Human platelets use a cytosolic Ca2+ nanodomain to activate Ca2+-dependent shape change independently of platelet aggregation

Human platelets use a rise in cytosolic Ca²⁺ concentration to activate all stages of thrombus formation, however, how they are able to decode cytosolic Ca²⁺ signals to trigger each of these independently is unknown. Other cells create local Ca²⁺ signals to activate Ca²⁺-sensitive effectors specifically localised to these subcellular regions. However, no previous study has demonstrated that agonist-stimulated human platelets can generate a local cytosolic Ca²⁺ signal. Platelets possess a structure called the membrane complex (MC) where the main intracellular calcium store, the dense tubular system (DTS), is coupled tightly to an invaginated portion of the plasma membrane called the open canalicular system (OCS). Here we hypothesised that human platelets use a Ca²⁺ nanodomain created within the MC to control the earliest phases of platelet activation. Dimethyl-BAPTA-loaded human platelets were stimulated with thrombin in the absence of extracellular Ca²⁺ to isolate a cytosolic Ca²⁺ nanodomain created by Ca²⁺ release from the DTS. In the absence of any detectable rise in global cytosolic Ca²⁺ concentration, thrombin stimulation triggered Na⁺/Ca²⁺ exchanger (NCX)-dependent Ca²⁺ removal into the extracellular space, as well as Ca²⁺-dependent shape change in the absence of platelet aggregation. The NCX-mediated Ca²⁺ removal was dependent on the normal localisation of the DTS, and immunofluorescent staining of NCX3 demonstrated its localisation to the OCS, consistent with this Ca²⁺ nanodomain being formed within the MC. These results demonstrated that human platelets possess a functional Ca²⁺ nanodomain contained within the MC that can control shape change independently of platelet aggregation.

Pyk2 downstream of G12/13 pathways regulates platelet shape change through RhoA/p160ROCK

Rho/Rho-kinase downstream of G_12/13 plays an important role in the regulation of calcium-independent platelet shape change. We have previously shown that proline-rich tyrosine kinase 2 (Pyk2) is activated downstream of G_12/13 pathways. In this study, we evaluated the role of Pyk2 in G_12/13-induced platelet shape change. We used low concentrations of YFLLRNP, a heptapeptide binding to protease-activated receptor 1 (PAR1), or PAR4-activating peptide AYPGKF in the presence of Gα_q inhibitor YM254890 to selectively stimulate G_12/13 pathways. We found that G_12/13-induced platelet shape change was completely inhibited in the presence of Pyk2 inhibitors AG17 and TAT-Pyk2-CT, suggesting an important role of Pyk2 in platelet shape change. In addition, AYPGKF-induced shape change in G_q -/- platelets was completely inhibited in the presence of AG17 or RhoA/p160^ROCK inhibitor Y27632, confirming the role of Pyk2 in RhoA-dependent shape change. Furthermore, AYPGKF-induced platelet aggregation and dense granule secretion were inhibited by blocking Pyk2 or RhoA. Finally, G_12/13-induced myosin phosphatase target subunit 1 (MYPT1) phosphorylation was inhibited by AG17, confirming that Pyk2 regulates RhoA/p160^ROCK activation in platelets. These results demonstrate that Pyk2 downstream of G_12/13 pathways regulates platelet shape change as well as platelet aggregation and dense granule secretion through the regulation of RhoA/p160^ROCK.

Modification of the Dialysate Port of Plasma Separators for Safe Blood Purification in Japan

A fatal mix-up of a hemofilter with a plasma separator occurred in 2011. The close resemblance between the two blood purification columns commonly used in Japan posed a fundamental risk for such mix-ups. Both the in-hospital case investigation committee and the relevant academic societies have independently proposed the modifications of the dialysate port (D port) of the plasma separator to avoid this type of misuse. To make these devices foolproof, medical professionals, including physicians and clinical engineers, and members of the Medical Technology Association of Japan discussed measures to prevent this type of recurrence. Since new standards were soon to be issued by the International Organization for Standardization (ISO), the modifications were temporarily postponed. In September 2016, the ISO released new standards for small-bore connectors. The shape changes of the D port from the current slip-in type (ISO8637) to the Luer lock type (ISO80369-7) had been already approved by the Ministry of Health, Labor and Welfare of Japan by the end of November 2018, including a temporal use of a converter to connect the current type of D port to the new type of blood circuit. We must address the next issue that the new standard and the older standard coexist in the clinical setting, which may create a new risk.

Shape change in the atlas with congenital midline non-union of its posterior arch: a morphometric geometric study

BACKGROUND CONTEXT

The congenital midline non-union of the posterior arch of the atlas is a developmental variant present at a frequency ranging from 0.7% to 3.9%. Most of the reported cases correspond to incidental findings during routine medical examination. In cases of posterior non-union, hypertrophy of the anterior arch and cortical bone thickening of the posterior arches have been observed and interpreted as adaptive responses of the atlas to increased mechanical stress.

PURPOSE

We sought to determine if the congenital non-union of the posterior arch results in a change in the shape of the atlas.

STUDY DESIGN/SETTING

This study is an analysis of the first cervical vertebrae from osteological collections through morphometric geometric techniques.

METHODS

A total of 21 vertebrae were scanned with a high-resolution three-dimensional scanner (Artec Space Spider, Artec Group, Luxembourg). To capture vertebral shape, 19 landmarks and 100 semilandmarks were placed on the vertebrae. Procrustes superimposition was applied to obtain size and shape data (MorphoJ 1.02; Klingenberg, 2011), which were analyzed through principal component analysis (PCA) and mean shape comparisons.

RESULTS

The PCA resulted in two components explaining 22.32% and 18.8% of the total shape variance. The graphic plotting of both components indicates a clear shape difference between the control atlas and the atlas with posterior non-union. This observation was supported by statistically significant differences in mean shape comparisons between both types of vertebra (p<.0001). Changes in shape were observed in the superior and inferior articular facets, the transverse processes, and the neural canal between the control and non-union vertebrae.

CONCLUSIONS

Non-union of the posterior arch of the atlas is associated with significant changes in the shape of the vertebra.

Injectable chondroplasty: Enzymatic reshaping of cartilage grafts

OBJECTIVE/HYPOTHESIS

To develop an injection-based enzymatic technique that selectively softens cartilage tissue for reshaping cartilaginous structures in the head and neck.

MATERIALS AND METHODS

Two groups were formed using fresh rabbit ears: (1) whole rabbit ear group; (2) composite graft group (2.5mm×3.0cm specimens sectioned from the central region of the pinna). Subperichondrial injections using three enzymes (hyaluronidase, pronase, and collagenase II) in sequence were performed for the experimental specimens from both groups. In the control specimens, phosphate buffered saline was injected in a similar fashion. The whole ear specimens were then photographed while held upright in the anatomical vertical position to evaluate for buckling, which corresponds to the integrity of the cartilage. In addition, backlight photography was performed for all specimens to further evaluate the effect of the enzymes, such that increased light intensity represents increased cartilage digestion.

RESULTS

The application of the digestive enzymes resulted in marked reduction of cartilage tissue matrix resiliency, while preserving overlying skin layers. Enzymatically treated whole pinnae buckled at the site where enzymes were delivered. Backlit images revealed increased local light intensity at the regions of digestion. There was no obvious destruction of the overlying skin upon visual inspection.

CONCLUSIONS

This study demonstrates the feasibility of injectable chondroplasty as a potential alternative method to conventional surgery for auricular cartilage reshaping. Sequential injection of hyaluronidase, pronase, and collagenase II into the subperichondrial space can be performed to digest and soften cartilage structure with minimal involvement of surrounding tissue. Future studies will need to include chondrocyte viability testing and optimization of delivery techniques.